2010Journal of Medical ForumRequires access

Distribution and Drug Resistance of Clinical Pseudomonas Aeruginosa Isolates

Han ChangHong

Open publisher page 0 citations

Abstract

Ojbective To investigate the distribution and drug resistance of clinical Pseudomonas aeruginosa isolates.Methods A statistic analysis for the specimen source,departments with infection and drug resistance condition to 250 isolates was conducted inretrospective manner.Results Among 250 strains 241(96.4%)come from sputum,the proportion of these strains from ICU was 65.2%,from neurology department was 18.4% mainly.The result of drug susceptibility showed that P.aeruginosa had a high resistance rate to the chloramphenicol,minocycline,gentamicin,piperacillin,cefotaxime,ceftriaxome and sulfonamides antibiotics,respectively,accounted for more than 70%,and had a lower resistance rate to carbapenem,amikacin,ceftazidime,the lowest was to imipenem(20%),and to amikacin(24.8%).Conclusion Clinical isolates of P.aeruginosa come from the sputum and ICU mainly,but their resistant rates are rather high and multi-drug resistant.We should pay more attention to the surveillance of antimicrobial resistance of P.aeruginosa in clinics.

About this research paper

What this paper is about

Ojbective To investigate the distribution and drug resistance of clinical Pseudomonas aeruginosa isolates.Methods A statistic analysis for the specimen source,departments with infection and drug resistance condition to 250 isolates was conducted inretrospective manner.Results Among 250 strains 241(96.4%)come from sputum,the proportion of these strains from ICU was 65.2%,from neurology department was 18.4% mainly.The result of drug susceptibility showed that P.aeruginosa had a high resistance rate to the chloramphenicol,minocycline,gentamicin,piperacillin,cefotaxime,ceftriaxome and sulfonamides antibiotics,respectively,accounted for more than 70%,and had a lower resistance rate to carbapenem,amikacin,ceftazidime,the lowest was to imipenem(20%),and to amikacin(24.8%).Conclusion Clinical isolates of P.aeruginosa come from the sputum and ICU mainly,but their resistant rates are rather high and multi-drug resistant.We should pay more attention to the surveillance of antimicrobial resistance of P.aeruginosa in clinics.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Ojbective To investigate the distribution and drug resistance of clinical Pseudomonas aeruginosa isolates.Methods A statistic analysis for the specimen source,departments with infection and drug resistance condition to 250 isolates was conducted inretrospective manner.Results Among 250 strains 241(96.4%)come from sputum,the proportion of these strains from ICU was 65.2%,from neurology department was 18.4% mainly.The result of drug susceptibility showed that P.aeruginosa had a high resistance rate to the chloramphenicol,minocycline,gentamicin,piperacillin,cefotaxime,ceftriaxome and sulfonamides antibiotics,respectively,accounted for more than 70%,and had a lower resistance rate to carbapenem,amikacin,ceftazidime,the lowest was to imipenem(20%),and to amikacin(24.8%).Conclusion Clinical isolates of P.aeruginosa come from the sputum and ICU mainly,but their resistant rates are rather high and multi-drug resistant.We should pay more attention to the surveillance of antimicrobial resistance of P.aeruginosa in clinics.

Key concepts: Amikacin, Pseudomonas aeruginosa, Imipenem, Cefotaxime, Piperacillin, Sputum, Drug resistance, Microbiology

Related papers

Back to paper searchBrowse research topicsOriginal source
Distribution and Drug Resistance of Clinical Pseudomonas Aeruginosa Isolates — Research Paper | ScholarLens